We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.59B
1-Year Est. Return 39.81%
This Fund
S&P 500
This Quarter Est. Return
-1.68%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$1.43B
AUM Growth
+$172M
Cap. Flow
+$215M
Cap. Flow %
15.04%
Top 10 Hldgs %
3.57%
Holding
2,136
New
582
Increased
568
Reduced
423
Closed
559

Top Sells

Rank Stock Value
1
JBSS icon
John B. Sanfilippo & Son
JBSS
+$3.41M
2
APA icon
APA Corp
APA
+$3.31M
3
ZTS icon
Zoetis
ZTS
+$3.2M
4
UGI icon
UGI
UGI
+$3.03M
5
DOCU
DocuSign
DOCU
+$2.87M

Sector Composition

Rank Sector Weight
1 Technology 15.39%
2 Healthcare 13.4%
3 Consumer Discretionary 13.25%
4 Financials 12.49%
5 Industrials 11.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ARCO icon
601
Arcos Dorados Holdings
ARCO
$1.74B
$862K 0.06%
95,795
+82,123
+601% +$845K
BKR icon
602
Baker Hughes
BKR
$61.1B
$862K 0.06%
24,496
+14,313
+141% +$469K
PFGC icon
603
Performance Food Group
PFGC
$18B
$862K 0.06%
+13,045
New +$909K
TK icon
604
Teekay
TK
$985M
$862K 0.06%
96,060
-88,949
-48% -$749K
TRS icon
605
TriMas Corp
TRS
$1.44B
$860K 0.06%
33,653
+17,727
+111% +$466K
FSLR icon
606
First Solar
FSLR
$26.9B
$859K 0.06%
3,809
-747
-16% -$163K
SEE
607
DELISTED
Sealed Air
SEE
$858K 0.06%
24,648
+15,721
+176% +$561K
NU icon
608
Nu Holdings
NU
$66.9B
$857K 0.06%
66,474
+231
+0.3% +$2.69K
KRP icon
609
Kimbell Royalty Partners
KRP
$1.48B
$856K 0.06%
+52,338
New +$852K
SAGE
610
DELISTED
Sage Therapeutics
SAGE
$855K 0.06%
78,749
+67,094
+576% +$860K
KPTI icon
611
Karyopharm Therapeutics
KPTI
$48M
$853K 0.06%
65,561
-21,049
-24% -$349K
RKT icon
612
Rocket Companies
RKT
$38.9B
$853K 0.06%
+62,243
New +$841K
CATY icon
613
Cathay General Bancorp
CATY
$4.24B
$850K 0.06%
+22,529
New +$817K
AM icon
614
Antero Midstream
AM
$10.1B
$848K 0.06%
57,519
-83,759
-59% -$1.2M
TMO icon
615
Thermo Fisher Scientific
TMO
$220B
$848K 0.06%
+1,534
New +$879K
FIRY
616
Firy Inc
FIRY
$163M
$846K 0.06%
+117,803
New +$766K
UVE icon
617
Universal Insurance Holdings
UVE
$1.23B
$844K 0.06%
+44,987
New +$875K
HVT icon
618
Haverty Furniture Companies
HVT
$454M
$843K 0.06%
+33,328
New +$963K
CFLT
619
DELISTED
Confluent
CFLT
$842K 0.06%
28,523
-7,678
-21% -$221K
DCH
620
Dauch Corp
DCH
$1.51B
$840K 0.06%
120,200
-37,581
-24% -$277K
LXFR icon
621
Luxfer Holdings
LXFR
$458M
$840K 0.06%
72,451
-19,267
-21% -$214K
AME icon
622
Ametek
AME
$58.2B
$838K 0.06%
+5,029
New +$869K
FULC icon
623
Fulcrum Therapeutics
FULC
$297M
$838K 0.06%
135,221
+120,059
+792% +$909K
WEX icon
624
WEX
WEX
$6.31B
$837K 0.06%
+4,725
New +$964K
REVG
625
DELISTED
REV Group
REVG
$835K 0.06%
33,553
-13,943
-29% -$342K

Similar funds

GSA Capital Partners's Q2 2024 Portfolio in Review

As of Q2 2024, GSA Capital Partners held 2,136 positions worth $1.43B, up 14% from $1.26B the previous quarter. Its ten largest holdings account for 3.6% of the portfolio.

GSA Capital Partners deployed $215M of net new capital in Q2 2024, opening 582 new positions and adding to 568 existing holdings. Its largest new stake was Genuine Parts: 28,253 shares worth $3.91M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 16% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was UGI, an estimated $3.03M trimmed.

  • GSA Capital Partners's largest Q2 2024 buy was Genuine Parts: 28,253 shares worth $3.91M.
  • GSA Capital Partners added most to Devon Energy in Q2 2024, an estimated $5.97M increase.
  • GSA Capital Partners's biggest Q2 2024 reduction was UGI, cutting an estimated $3.03M.
  • GSA Capital Partners fully exited John B. Sanfilippo & Son in Q2 2024, selling an estimated $3.41M.
  • GSA Capital Partners's ten largest holdings make up 3.6% of its $1.43B portfolio in Q2 2024.
  • GSA Capital Partners opened 582 new positions and closed 559 in Q2 2024.
  • GSA Capital Partners's portfolio value rose 14% quarter-over-quarter to $1.43B.

Based on GSA Capital Partners's 13F filing for Q2 2024, filed 15 Aug 2024.